1.
J Pediatr Hematol Oncol
; 39(2): 156-158, 2017 03.
Article
in English
| MEDLINE
| ID: mdl-28060107
Subject(s)
Anti-Infective Agents/therapeutic use , Cytoreduction Surgical Procedures , Leukostasis/drug therapy , Lung Diseases/drug therapy , Child , Cytarabine/therapeutic use , Humans , Leukostasis/pathology , Leukostasis/surgery , Lung Diseases/pathology , Lung Diseases/surgery , Male , Prognosis
2.
J Pediatr Hematol Oncol
; 39(2): e59-e61, 2017 03.
Article
in English
| MEDLINE
| ID: mdl-27606438
ABSTRACT
Vitamin D receptor (VDR) polymorphisms are found more commonly in some tumor types than in healthy individuals, suggesting that some polymorphisms (Cdx2, Fok1, Bsm1, Apa1, Taq1) contribute to tumor development. There is no previous report on VDR polymorphism in Hodgkin's lymphoma (HL) patients. VDR polymorphism patterns in 95 pediatric HL cases with 100 healthy controls were compared. No statistically significant difference was found between the patient group and control group in terms of Cdx2, Fok1, Bsm1, Apa1, and Taq1 polymorphisms (P>0.5). Our findings suggest that VDR polymorphisms may not play a role in HL development.
